Evidence map›Paper›PMID 27966542›Full record

ArticleEuropean journal of human genetics : EJHG2017

Epilepsy-causing sequence variations in SIK1 disrupt synaptic activity response gene expression and affect neuronal morphology.

Christoph Pröschel, Jeanne N Hansen, Adil Ali, Emily Tuttle, Michelle Lacagnina, Georgia Buscaglia, Marc W Halterman, Alex R Paciorkowski

Open access · bronzeAbstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Protective effects of the saltZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. ATranslational pediatrics · 2021
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Christoph PröschelDepartment of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA.
Jeanne N HansenDepartment of Pediatrics, University of Rochester Medical Center, Rochester, NY, USA.
Adil AliCenter for Neural Development and Disease, University of Rochester Medical Center, Rochester, NY, USA.
Emily TuttleCenter for Neural Development and Disease, University of Rochester Medical Center, Rochester, NY, USA.
Michelle LacagninaDepartment of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA.
Georgia BuscagliaDepartment of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA.
Marc W HaltermanCenter for Neural Development and Disease, University of Rochester Medical Center, Rochester, NY, USA.
Alex R PaciorkowskiDepartment of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA.
University of Rochester Medical Center · US

Funding

Resource in Education in Microbiology and ImmunologyR25GM064133 · NIGMS · UNIVERSITY OF ROCHESTER · PI LORD, EDITH M · 2002 to 2017
$4.2M
Targeting phosphatase regulated cleavage of HIF-1-alpha in ischemic brain injuryR01NS076617 · NINDS · UNIVERSITY OF ROCHESTER · PI HALTERMAN, MARC W · 2011 to 2015
$1.6M
Biology of developmental encephalopathies presenting with infantile spasmsK08NS078054 · NINDS · UNIVERSITY OF ROCHESTER · PI PACIORKOWSKI, ALEXANDER R · 2013 to 2017
$779k
NIGMS NIH HHS R25 GM064133NINDS NIH HHS K08 NS078054NINDS NIH HHS R01 NS076617
6 · The paper itself

Abstract

SIK1 syndrome is a newly described developmental epilepsy disorder caused by heterozygous mutations in the salt-inducible kinase SIK1. To better understand the pathophysiology of SIK1 syndrome, we studied the effects of SIK1 pathogenic sequence variations in human neurons. Primary human fetal cortical neurons were transfected with a lentiviral vector to overexpress wild-type and mutant SIK1 protein. We evaluated the transcriptional activity of known downstream gene targets in neurons expressing mutant SIK1 compared with wild type. We then assayed neuronal morphology by measuring neurite length, number and branching. Truncating SIK1 sequence variations were associated with abnormal MEF2C transcriptional activity and decreased MEF2C protein levels. Epilepsy-causing SIK1 sequence variations were associated with significantly decreased expression of ARC (activity-regulated cytoskeletal-associated) and other synaptic activity response element genes. Assay of mRNA levels for other MEF2C target genes NR4A1 (Nur77) and NRG1, found significantly, decreased the expression of these genes as well. The missense p.(Pro287Thr) SIK1 sequence variation was associated with abnormal neuronal morphology, with significant decreases in mean neurite length, mean number of neurites and a significant increase in proximal branches compared with wild type. Epilepsy-causing SIK1 sequence variations resulted in abnormalities in the MEF2C-ARC pathway of neuronal development and synapse activity response. This work provides the first insights into the mechanisms of pathogenesis in SIK1 syndrome, and extends the ARX-MEF2C pathway in the pathogenesis of developmental epilepsy.

Indexed as

MutationSynaptic TransmissionCells, CulturedCytoskeletal ProteinsEpilepsyHEK293 CellsHumansMEF2 Transcription FactorsNerve Tissue ProteinsNeuregulin-1NeuronsNuclear Receptor Subfamily 4, Group A, Member 1Protein Serine-Threonine Kinasesactivity regulated cytoskeletal-associated proteinCytoskeletal ProteinsMEF2C protein, humanMEF2 Transcription FactorsNerve Tissue ProteinsNeuregulin-1NR4A1 protein, humanNRG1 protein, humanNuclear Receptor Subfamily 4, Group A, Member 1Protein Serine-Threonine KinasesSIK1 protein, human

Identifiers

PMID27966542
PMCPMC5255945
OpenAlexW2561871961

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.